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Summary 
The delivery of HIV care in the initial rapid scale-up of HIV care and treatment was based on existing clinic-
based models, which are common in highly resourced settings and largely undifferentiated for individual 
needs. A new framework for treatment based on variable intensities of care tailored to the specific needs 
of different groups of individuals across the cascade of care is proposed here. Service intensity is character-
ized by four delivery components: (1) types of services delivered, (2) location of service delivery, (3) provid-
er of health services, and (4) frequency of health services.  How these components are developed into a 
service delivery framework will vary across countries and populations, with the intention being to improve 
acceptability and care outcomes. The goal of getting more people on treatment before they become ill will 
necessitate innovative models of delivering both testing and care.  As HIV programs expand treatment eli-
gibility, many people entering care will not be “patients” but healthy, active and productive members of 
society.1 In order to take the framework  to scale, it will be important to: (1) define which individuals can be 
served by an alternative delivery framework; (2) strengthen health systems that support decentralization, 
integration and task shifting; (3) make the supply chain more robust; and (4) invest in data systems for pa-
tient tracking and for program monitoring and evaluation. 
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Introduction 
The widespread devastation caused by the HIV pandemic has led to unprecedented increases in overseas 
development aid for health, much of it earmarked for care and treatment-related services in low and mid-
dle income countries.2 The magnitude of HIV funding allowed for rapid strengthening of under-resourced 
health systems unaccustomed to providing chronic care and enabled the successful expansion of care and 
treatment services that have averted an estimated 5.5 million deaths since 1996.3,4 Further expansion of 
the emergency scale-up, as currently constituted, is constrained by the donor funding environment 5,6 and 
subsequent increases in donor resources are unlikely.   
 
A sequel of this success story, however, is that health systems have become even more overbur-
dened. The models of delivery for HIV care developed for the initial rapid scale-up of HIV services were 
based on traditional clinic-based service models, common in highly resourced settings, and largely not mod-
ified to reflect individual needs. Even as the number of people on ART has grown to almost 12 million in low 
and middle income countries, protocols for frequent clinic follow-up have been perpetuated with very few 
changes, regardless of how long an individual has been on antiretroviral treatment (ART) or their clinical 
status. After the early rapid growth in clinic sites, expansion has slowed and ever-growing numbers of peo-
ple receive care in clinics often with  insufficient numbers of doctors, clinical officers and nurses.7  As a re-
sult of traditional care models, HIV clinics are crowded and waiting times are long with many people wait-
ing solely to pick up drug refills.  Health care workers are over-taxed due to this high workload and, due to 
weak infrastructure, face challenges to provide care and follow-up according to the guidelines on which 
they have been trained.  
 
These challenges have led to a mixed picture of effectiveness among the HIV care and treatment systems.  
On the one hand individuals who have been linked to care and retained on ART achieve high rates of viral 
suppression.8–10 However, studies report substantial loss to follow up across all steps of the care cascade.6,11 
Overburdened health systems, lack of patient-focused services, resource limitations, and mixed quality of 
care have led to efforts to modify the delivery of HIV care in a framework that addresses the causes of  
poor retention. Task shifting is one of the most common approaches.12  WHO has included task shifting in 
the 2013 Consolidated Guidelines as a way of providing care to a greater number of people at reduced cost 
or when there are insufficient health care workers in the public sector.13 Other programs have focused on 
decentralization, shifting care to primary health clinics and to the communities in which people  live.14  
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We describe a delivery framework which provides differential care and treatment services for specific, well-
defined groups of people  in an effort to improve service quality and access, adherence and retention, out-
comes, efficiency, and cost of services. The framework has been variously termed optimized care, patient-
centered/focused care, needs-based care or tiered care.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A framework for delivering HIV care and treatment 
Driven by a desire to provide care which people will use and to increase the efficiency and effectiveness of 
HIV care delivery, this framework aims to vary the intensity of both ART and pre-ART care based on individ-
ual need and to create more flexible, convenient, and acceptable models of service delivery for patients, 
health care workers, and health systems. In simple terms, the framework describes delivery of the right 
care at the right frequency to the right individuals by the right care providers in the right location at the 
right time. Although this concept is not new, it has not been extensively used by HIV care and treatment 
programs in low and middle income countries to date.  
The framework involves providing differential intensity of care and treatment services across de-
fined patient strata. Service intensity is characterized by four components, all centered on the needs of in-
dividuals: (1) types of services delivered; (2) location of service delivery; (3) provider of health services; and 
(4) frequency of health services.  
PROBLEM STATEMENTS
1. The scale up of ART in low and middle income countries has 
led to overburdened health systems 
• HIV clinics are overcrowded and waiting times are long  
• Many countries lack sufficient clinical personnel to treat 
the increasing numbers of patients eligible for ART 
• Health systems are geared to acute disease response ra-
ther than to providing chronic care  
 
2. The needs of people who are stable on and adherent to 
ART are different to those of people who are unwell or 
non-adherent 
• Current models of care are not patient centered 
• People with  widely divergent needs have only one ac-
cess point to the clinic to receive care 
• Stable people do not need regular contact with the 
health care facility 
 
3. Alternative care models implemented in resource limited 
settings have not been taken to scale 
• There are limited robust measures of impact and out-
comes of alternative delivery frameworks 
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Figure 1: Four levers to tailor or adapt care to people’s needs (service frequency, location, intensity and ca-
dre) 
 
  
Each of these components represents a flexible lever for adjusting or modifying a model of care to serve a 
specific patient stratum in a given geographic or health system setting. Health system variables, such as ge-
ography, level of health facility, available cadres of health workers, and individual variables (distance to the 
health facility, clinical condition, social and economic situation, education level, rural/urban context, and 
mobility pattern) determine how levers are applied in a given location. How the framework is implemented 
will vary across countries and populations in order to best serve the needs of individuals. Similarly, individ-
ual eligibility criteria will vary by heath setting, with the intention being to improve patient acceptability 
and care outcomes.   
Different intensities of service can be delivered within a single location or between locations. Dis-
tribution of individuals into strata for optimized care is determined by the needs and preferences as de-
fined by specific characteristics (Table 1). The distribution of individuals across care strata is dynamic due to 
the need for periodic up-referral or down-referral to more or less intensive care based on their current 
needs. 
 
Table 1: Key determinants of stratification into different levels of care 
Clinical determinants Social/cultural determinants
Knowledge of HIV status 
HIV disease severity and current health status 
Individuals’ support network
Individuals’ preference for specific model of care 
Duration of care or treatment Distance from home to healthcare facility 
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Treatment tolerance and adherence Socio-cultural factors (family, work, or communi-
ty barriers to care) 
 
Models of care can be or-
ganized into three catego-
ries based on the location 
at which people receive 
services. Centralized, facil-
ity based models can pro-
vide differential care with-
in a single health facility, 
such as  reduced frequency 
of visits or substitution of a 
clinical assessment visit by a pharmacy only medication refill visit. Decentralized models of care provide 
pre-ART and ART services either by down-referring stable people or initiating and managing people at more 
peripheral health facilities.15,16 Other models decentralize care even further by providing care directly in the 
community or in the home. 
There are critical enabling services that are levers for successful HIV health delivery regardless of 
location, intensity, and frequency of care and who delivers that care. The need for psycho-social support, 
transportation, child care, nutrition, legal and other services may be as important as how long people wait 
in clinic.  
 
Examples and evidence from the literature  
Application of individual elements of this care framework, notably decentralization and task shifting, has in-
creased significantly during the past few years and has been widely endorsed by the WHO and other agen-
cies. However, there are few models that represent differential HIV care intensity across patient strata in 
either the peer reviewed literature or the grey/conference literature.  While not a systematic review, the 
examples presented in Table 2 illustrate the key dynamics and outcomes of innovative models of care in 
the real world. The studies included in this analysis reported results from approximately 68,000 HIV-
positive individuals in eight countries (Democratic Republic of the Congo, Kenya, Malawi, Mozambique, 
South Africa, Swaziland, Thailand, and Uganda). See Table 2 in the annex for a detailed listing of studies and 
results. 
All of the models analyzed differentiated individuals on the basis of clinical stability on treatment to 
determine eligibility for an alternative framework of care.  Eligibility was generally restricted to adults with 
CD4 count above a certain threshold (ranging from ≥50 to ≥350), a certain length of time on ART (from ≥4 
weeks to ≥18 months and adherent), undetectable viral load and/or other clinical considerations (no oppor-
Figure 2: Categories of Care Models 
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tunistic infections, no adverse reactions, not pregnant).  The studies generally reported on outcomes (in-
cluding loss to follow-up, mortality and adherence), and some studies reported changes in resource use 
(health system and/or cost per person per year, number of clinic visits).   
 
Examples of models and evidence of impact 
One study examined the cost-effectiveness of the centralized, facility-based model in an urban HIV clinic.17   
At the Infectious Diseases Institutes (IDI) in Kampala, Uganda, stable individuals are offered 3 monthly 
nurse visits, 6 monthly physician visits and monthly pharmacy only ART refills. Individual outcomes were 
similar between those managed with monthly refill visits and standard monthly physician/nurse visits but 
the cost per person per year fell from $610 per year to $496 for monthly refill-only visits, a decrease of 
nearly 20%.17 
A clinic-based model that used a six monthly clinical appointments (SMA) program was initiated at 
the Chiradzulu District Hospital in rural Malawi and supported by Médecins Sans Frontières (MSF) to reduce 
waiting times and clinic staff workload using visit spacing and pharmacy only visits.18  This program enrolled 
people stable on ART to receive 6-monthly clinical appointments with nurses and 3-monthly drug refill vis-
its. Between January 2008-mid-2013, 8,528 adults were enrolled in SMA. Cohort retention at 36 months af-
ter SMA start was 94%, however 2722 (33%) people had returned to standard clinical follow-up status.  
Reasons for SMA discontinuation and long-term treatment outcomes are being evaluated.18  
 
 A number of studies evaluated the impact of a decentralized, facility based model in which 
stable individuals were down-referred from the HIV clinic (where care was generally provided by a doctor 
or clinical officer) to a primary care health center (where the care was generally provided by a nurse).  
Among the 39,000 individuals included in a meta-analysis of this approach, loss to follow up per 100 patient 
years was 7.4 (95% CI 6.0 – 9.3) in the primary care center group compared to 13.4 in the HIV clinic group 
and mortality per 100 patient years was 2.8 (95% CI 1.1 to 7.3) in the primary care center group compared 
to 8.4 in the HIV clinic group.14   
At the Themba Lethu Clinic in Johannesburg, South Africa, stable individuals were down referred to 
nurse-managed primary care clinics for treatment maintenance rather than being maintained at the HIV 
clinic.19–21  More than 2,000 individuals were down-referred as of 2011, and a matched cohort analysis 
found that down-referred people were less likely to die (HR 0.2; 95% CI 0.04-0.8), or be lost to follow-up 
(HR 0.3; 95% CI 0.2-0.6) or experience viral rebound (RR 0.6; 95% CI 0.4-0.9).19  The cost of care in primary 
clinics was 11% less than in the HIV clinic.20  Similar care models have been introduced in rural areas of 
South Africa with similar outcomes.21  
 A number of different approaches have decentralized care to the community or to the 
home.  These models minimize the number of required clinic visits by utilizing community health workers 
or peers to deliver care or treatment either at home or at a community meeting point.  The community 
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health workers ranged in education and training, and the qualifications and pay for community health care 
workers varied throughout the models.  Some models used volunteers with few education requirements22 
while others recruited paid staff with college degrees23.  One model provided decision support tools to the 
community health workers.24  Two models used groups of people living with HIV (PLHIV) 25,26 while others 
used community health workers to deliver medication directly to the house22,24,27 or distributed treatments 
in community meeting points18.  All models reported reduced loss to follow-up and reduced number of clin-
ic visits among patients managed in the community or at home.   
One decentralized model is of particular interest in urban, high-density areas due to the degree it 
has been scaled and evaluated.  In the Western Cape of South Africa, MSF, driven by the need to provide 
better patient-centered care and to decongest over crowded HIV clinics, developed a model in which care, 
including ART drug refills, is provided either at the clinic or in community venues in a group setting.26  These 
groups, referred to as ART adherence clubs, are facilitated by a community health care worker. Forty-
month retention in the clubs in Khayelitsha is 97% (club) versus 83% (clinic) with a 67% reduction in virolog-
ical rebound among those in clubs compared to clinics.26 While there is selection bias since those eligible 
for club care are, by definition, stable and adherent, adherence and retention have remained high despite a 
reduction in clinic visits. This model has been adopted by the Metro District Health Servicesi from the initial 
MSF project in Khayelitsha to include 27,800 people (1/4 of total individuals in care by end June 2014) in 
the Cape Town metropolitan region.26 Roll out of the same care model has commenced in some districts in 
Gauteng and Free State provinces, while Swaziland is likely to implement the model in 2015.  
 
In Mozambique, MSF has collaborated with the Health Ministry to implement and scale Community 
ART Groups (CAGs) throughout the country.25  CAGs are groups of six individuals from which one rotating 
person in the group acts as the monthly ART collector for all members. Thus, each CAG member visits the 
clinic every six months. Eligible people must be stable on ART for >6 months and a CD4 count >200. Reten-
tion at 12, 24, 36, 48 months, respectively, has been 97.7%, 96%, 93.4%, and 91.8% and mortality has been 
2.1 per 100 person years.25  CAGs are being implemented at varied degrees of scale in Lesotho, Zimbabwe, 
Malawi, and South Africa.  
 
Limitations of the studies 
The field of research on alternative delivery frameworks is nascent and a number of important questions 
remain.  The articles we found did not discuss the impact on people who remained in standard clinic care or 
the impact on care providers. Only two studies were randomized and most were retrospective cohort stud-
ies.  While models have been implemented in a number of countries, 6 of the 16 models and approximately 
48,000 of the 68,000 people who were delivered care in this framework were in South Africa, often in ur-
                                                            
i Metro District Health Services provides comprehensive primary health service, mainly to lower income groups in the Cape Town 
metropolitan region. 
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ban settings. A model that is effective in urban South Africa, where resources and infrastructure are gener-
ally better, may not be reproducible with similar results in more resource-limited settings, such as Malawi, 
Mozambique, Zambia, or even rural South Africa.  
 
Implementation challenges 
Challenges to implementing this framework include defining the most appropriate selection criteria for re-
duced intensity or non-clinic care, national and local regulatory and policy frameworks around reduced in-
tensity of services, supply chain management and data systems for patient tracking and program monitor-
ing and evaluation.  
Each country has their own regulatory frameworks that establish the scope of work for each cadre 
of health care worker.  These regulations determine which cadre can initiate and/or manage antiretroviral 
therapy, dispense medications, and perform laboratory tests.  Further, regulations stipulate the frequency 
at which medications may be dispensed. These regulations significantly impact the ability to decentralize or 
temporally space care.  For example, ARV dispensing for individual patients in Western Cape was main-
tained centrally at pharmacy level, while distribution of pre-packed and labeled ART was permitted at lower 
level facilities and through community-based adherence clubs.  At present in many clinics in eastern, cen-
tral, and southern Africa, nurses cannot initiate ART , though WHO guidelines support it.28   
Supply chains and stock management must be sufficiently robust to ensure stable ART distribution 
for decentralized primary health centers and community-delivered ART along with longer durations of re-
fills (ideally three monthly).  
Robust data systems are necessary to track individuals across care sites as well as monitor overall 
program effectiveness, in particular to ensure that retention in care can be tracked as patients move be-
tween care facilities or settings.  Community delivered ART requires simple and robust data collection. 
Unique identifiers, referral tools and data management systems are needed. 
 
Conclusions 
We believe this framework can guide policy makers into introducing and scaling up new approaches to de-
livery across the HIV cascade of care. The framework is driven by two needs. First, care that better meets 
the needs of people and assisting them to access care and remain in care for life. Second, with donor fund-
ing for HIV expected to remain constant or decline in the coming years, this framework may provide a tool 
to provide this care more economically. The cost and cost effectiveness of innovative models delivery of 
care needs further evaluation.  
The framework, with its levers and patient centeredness, addresses the losses described by others 
across the cascade of testing, linkage and retention in care.6  Differentiated testing and linking strategies 
using new testing technologies such as oral self-test may hold promise in helping hard-to-reach populations 
know their HIV status.28–30The framework is equally applicable to pre-ART care as it is to ART care.  
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Scale-up of innovative models of care should be monitored and evaluated through a robust imple-
mentation science framework targeting critical questions about most effective and efficient approaches to 
providing care in varied settings. As best practices are identified, normative bodies and lead implementers 
should continue to develop toolkitsii and guidelines to help countries and providers to implement these ap-
proaches.  
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Annex: Table2 
Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
Centralized Models 
Kampala, Ugan-
da. 29 
6/2006 – 7/2007 
Monthly pick-up 
of medication at 
pharmacy, whe-
re routine 
screening is 
completed.  SOC 
is monthly visit 
to clinic with 
physician. 
578 in the in-
tervention 
group. 
Urban 
Health Ser-
vice Provid-
er 
CD4≥200; ≥12 
months of ART; 
self-reported 
adherence 
≥95%; adher-
ence to sched-
uled clinic visits 
for last six 
months; dis-
closed status 
to spouse; not 
pregnant; no 
substantial 
clinical event in 
last 6 months. 
Monthly in 
the phar-
macy by a 
pharmacy-
based nurse 
Pharmacy-
based nurse 
asked screen-
ing questions; 
Physician visit 
every 6 
months 
Favorable 
immune re-
sponse after 
one year 
(CD4≥500): 
18.9% vs 
19.6%; com-
parison group 
was a 
matched 
sample before 
PRP who were 
followed for 
at least one 
year after ini-
tiating ART. 
$496 per 
year vs $610 
per year 
Costs in-
clude: ART, 
other drugs, 
radiology, 
labs, health 
personnel, 
and over-
head and 
capital. 
Decentralized Models 
Free State, 
South Africa 21 
January 2008 – 
June 2010 
In one cohort 
(top row) ART 
initiation and 
management 
Initiation and 
management 
5,390 
Rural and Ur-
ban 
Health Ser-
vice Provid-
er, Location 
CD4 between 
51 and 200; no 
Stage IV infec-
tion; no previ-
ous ART ≥1 
month; no 
drugs other 
than 
Monthly in 
the primary 
care clinic 
by a nurse 
Routine, not 
discussed in 
article; care 
provided in 
health center 
by nurse. 
Mortality per 
100 person 
years: 1.34 vs 
1.44  
Program re-
tention: 63% 
vs 58%* 
Random as-
Shorter com-
mute to com-
munity clinic, 
not quantified 
in study. 
Significant 
training for 
nurses and 
nurse manag-
ers (4 ses-
sions), plus 2.5 
day train the 
trainer session 
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Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
was completed 
in nurse-led 
primary care 
clinic.  In the 
other cohort 
(bottom row) 
ART manage-
ment provided 
in nurse-led 
primary care 
clinic. SOC is ini-
tiation and 
management at 
physician-led 
HIV clinic.   
 
cotrimoxazole 
or vitamins, 
not bed-or 
wheelchair 
bound; 
Weight>40kg; 
BMI<28 
signment by 
primary care 
clinic. 
Management 
3029 
Rural and Ur-
ban 
Health Ser-
vice Provid-
er, Location 
Undetectable 
VL; no severe 
side effects; no 
new opportun-
istic infections 
Monthly in 
a primary 
care clinic 
by a nurse 
Routine, not 
discussed in 
article; care 
provided in 
health center 
by nurse. 
Suppressed 
VL: 71% vs 
70% 
Program re-
tention: 90% 
vs 91% 
Random as-
signment by 
primary care 
clinic. 
 
Shorter com-
mute to com-
munity clinic, 
not quantified 
in study. 
Significant 
training for 
nurses and 
nurse manag-
ers (4 ses-
sions), plus 2.5 
day train the 
trainer session 
South Africa (3), 
Malawi (1), 
Swaziland (1), 
Thailand (1) 14 
Study data  
range from 2004 
through 2009 
Partial decen-
tralization – 
23,217 indi-
viduals 
decentrailized; 
15,980 in con-
trol; three 
studies fo-
cused only on 
adults, two on 
children, one 
Health Ser-
vice Provid-
er, Location 
Varies, one 
study included 
only treatment 
naïve patients, 
three on stable 
patients with 
minimum time 
on ARV be-
tween 4 weeks 
Studies did 
not vary 
frequency 
of care/ART 
distribution.  
Initiation 
was at the 
hospital by 
a doctor or 
Varies, but 
generally by 
nurse at 
health center 
Lost to care 
per 100 pa-
tient years: 
7.4 vs 13.4* 
Mortality per 
100 patient 
years:  2.8 vs 
8.4* 
Note: these 
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Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
treatment initia-
tion in a hospital 
with follow-up 
care provided by 
a health center 
 
on both  
Rural, peri-
urban, and ur-
ban 
and 11 months, 
and one with 
limited re-
quirements. 
clinical of-
ficer, while 
follow-up 
care pro-
vided at 
health cen-
ters by a 
nurse. 
amounts are 
for 12-month 
follow-up of 
four of six 
studies.  Ac-
count for 
nearly all par-
ticipants.  Two 
excluded stud-
ies are small 
and excluded 
b/c they don’t 
provide 12-
month time 
point. 
South Africa(1), 
Malawi (2), 
Ethiopia(2), 
Kenya, Mozam-
bique, Rwanda, 
Tanzania, Leso-
tho 14 
Study data 
range from 2004 
through 2010  
Full decentrali-
zation – treat-
20,448 indi-
viduals fully-
decentralized; 
48,096 con-
trol; four stud-
ies focused 
only on adults, 
one only on 
children, and 
one on both 
All studies in-
clude rural pa-
Task shift-
ing, location 
Varies, most 
studies do not 
note exclusion 
criteria, one 
study required 
individuals to 
be on treat-
ment for less 
than 6 months, 
another re-
quired treat-
ment naïve pa-
Studies did 
not vary 
frequency 
of care/ART 
distribution. 
Initiation 
and follow-
was done at 
a primary 
health cen-
ters. All 
studies 
Varies, but 
generally by 
nurse at 
health center 
Lost to care 
per 100 pa-
tient years: 
8.1 vs 27.0* 
Mortality per 
100 patient 
years:  10.6 vs 
9.7 
Note: these 
amounts are 
for 12-month 
follow-up of 
 
 
 
A
c
c
e
p
t
e
d
 
A
r
t
i
c
l
e
 
 
 
This article is protected by copyright. All rights reserved. 
Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
ment initiation 
and manage-
ment provided 
by health center 
 
tients, two in-
clude urban 
patients as 
well 
tients. used nurs-
es, two also 
used physi-
cians, three 
used medi-
cal officers, 
and two 
used medi-
cal assis-
tants.  
four of six 
studies.  Ac-
count for 
nearly all par-
ticipants.  Two 
excluded stud-
ies are small 
and excluded 
b/c they don’t 
provide 12-
month time 
point. 
Chiradzulu Dis-
trict, Malawi 18 
1/2008 – 6/2013 
Intervention 
group could pick 
up medication 
at health center 
every three 
months.  Clinic 
visits every 6 
months.  Care at 
health center 
provided by 
CHW.  SOC is 
clinic visit every 
5,869 received 
intervention, 
which was 
21% of active 
ART cohort; 
2,722 (33% of 
original enrol-
lees) returned 
to standard 
clinical follow-
up status. 
Rural 
Health Ser-
vice Provid-
er, Frequen-
cy, Location 
Stable adult 
patients - ≥15 
on first-line 
ART for ≥12 
months;  CD4  
≥300; no OI or 
side effects; no 
pregnancy or 
breastfeeding 
Clinic every 
6 months vs 
1-2 months; 
3-month 
ART refills 
at health 
centers by a 
community 
health 
worker 
Monitored via 
standardized 
assessment 
tool at each 
visit; Clinic vis-
its every 6 
months. 
36-month Re-
tention: 94% 
vs  83% 
Lost to follow-
up (1, 2, 5 
yrs.):– 1.3%, 
2.98%, 7.8%; 
Mortality (1, 
2, 5 yrs.) - 
.4%, .9%, 
2.8%. 
Comparison 
with those eli-
gible for but 
not enrolled in 
Paid communi-
ty health 
workers; sup-
ply chain that 
can accommo-
date 3-month 
prescriptions 
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Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
1-2 months. intervention.
Lubombo, Swa-
ziland30 
January 2007 –
November 2007 
Intervention 
group received 
care in primary 
care health clin-
ic by nurse. SOC 
is monthly visit 
to central HIV 
clinic and receiv-
ing care from 
clinical officer.   
317 were in-
cluded in the 
study of the 
425 invited 
from the in-
tervention 
clinic 
Rural 
Health Ser-
vice Provid-
er, Location 
≥14; on ART for 
≥4 weeks; 
CD4≥100; clini-
cally suitable 
Monthly at  
primary 
care clinic 
by  a coun-
sellor and 
nurse evolv-
ing to pri-
mary care 
nurse and 
staff 
Blood test, 
clinical ques-
tionnaire; 
care provided 
at health cen-
ter by nurses 
No missed 
appointments  
- 89.6% vs 
72%*  
Loss to fol-
low-up: 2.8% 
vs 1.3% 
Mortality: 0 
vs 2.5%* 
Comparison 
population 
were individ-
uals who 
would have 
been eligible 
for the study, 
but receive 
care from a 
different clini-
cal area. 
Average cost 
of round trip 
transportation 
was halved 
($.74 vs $1.5); 
53% of inter-
vention group 
said transpor-
tation cost was 
lowered.  Oth-
er benefits re-
ported include 
being nearer 
to home, 
shorter waits, 
better treat-
ment by staff, 
better care.   
Initial training 
of primary care 
team 
South Africa 19,20  
February 2008 
through January 
2009 (Study 
timeline, initia-
tion interven-
693 in study, 
~2,000 in total 
down-
referred. 
Urban 
Health Ser-
vice Provid-
er, Location 
ART≥11 
months; no 
opportunistic 
infections; 
CD4>200; sta-
ble weight as 
Every two 
months at 
the primary 
care clinic 
by a prima-
ry care 
Weight loss; 
symptoms 
other visit to 
medical facili-
ty; blood test 
every 6 
Mortality per 
100 patient 
years: .3 vs 
1.6*; 
Lost to follow-
up: 1.4% vs 
Costs re-
duced by 
11% - $492 
pppy vs 551.  
Cost effec-
tiveness in-
EHR system 
that enables 
communication 
between clinic 
and initiation 
site; 6 week 
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Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
tion began in 
2007) 
Care and medi-
cation distribu-
tion provided at 
nurse-led prima-
ry care clinic 
every two 
months. SOC is 
bi-monthly visits 
to HIV clinic 
with physician.  
reflected by
<5% weight 
loss between 
the last three 
visits; VL unde-
tectable  
nurse months; care 
provided at 
primary care 
health center 
by nurse 
4.2%*
Matched co-
hort using 
propensity 
scores based 
on gender, 
age, months 
on ART, ARV 
regimen, BMI, 
CD4 count 
 
creased: 
$509 to $602 
per person in 
care and re-
sponding to 
treatment 
Costs includ-
ed: ARVs, 
other drugs, 
labs, outpa-
tient visits, 
fixed costs 
ART specific 
training for 
primary care 
health nurses. 
Community and Home-based models 
Khayelitsha, 
South Africa  
18,26 
11/2007 – 
6/2013 
Medications dis-
tributed via 
community 
health worker-
led 30 person 
support groups 
bi-monthly.  
SOC is monthly 
visits with medi-
776 clubs have 
formed as of 
publication.  
18,719 receiv-
ing care 
through the 
intervention, 
which is 19% 
of active ART 
cohort 
Urban 
Health Ser-
vice Provid-
er, Location 
Adult on 1st
line for ≥18 
months; two 
undetectable 
VL; CD4>200;  
Criteria for re-
turn to clinic 
care: Missed 
club visit (5 day 
grace) or clini-
cally unstable 
including high 
VL 
Every two 
months at 
meetings 
which take 
place either 
at clinic or 
community 
location, 
provided by 
community 
health 
workers. 
Bi-monthly 
weight, symp-
tom based 
general as-
sessments; at-
tendance; 
nurse review 
twice per year 
(1 clinical, 1 
blood test).  
Nurse attends 
meetings only 
during these 
sessions. 
Lost to care 
(including 
death, per 
100 person 
years: 2.98 vs 
11.69* 
Virological 
rebound per 
100 person 
years: 3.18 vs 
9.04* 
Comparison 
population 
had been on 
Shorter wait-
ing times; 
higher accept-
ability of ser-
vices; fewer 
missed ap-
pointments 
$58 per year 
vs $109 in 
SOC (unclear 
what is in-
cluded, cita-
tion to a con-
ference ab-
stract) 
Pharmacy staff 
to pre-package 
drugs for 
groups, well-
trained lay-
workers and 
support for lay-
workers, regis-
tries 
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Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
cal staff. ARVs for a 
similar period 
of time. 
Kinshasa, Dem-
ocratic Republic 
of the Congo18 
12/2010 – 
5/2013 
Medications dis-
tributed at 
community dis-
tribution points 
by peers every 3 
months.  SOC is 
visits to clinic 
(timing of SOC is 
not described.)  
2,161 referred 
to community 
ART distribu-
tion sites, 
which is 43% 
of active ART 
cohort 
Urban 
Health Ser-
vice Provid-
er, Frequen-
cy (?), Loca-
tion 
 
On 1st line ART 
for ≥6 months;  
CD4≥350; no 
OI or side ef-
fects 
Every 3 
months at 
community 
ART distri-
bution 
points by 
peers. 
Basic health 
indicators 
monitored by 
peer distribu-
tor; annual 
clinical con-
sultation and 
blood test 
(CD4) at clinic 
Retention at 
12 months, 24 
months: 
89.3%, 82.4%; 
reported re-
tention of 75-
85% reported 
elsewhere 
Lost to follow-
up at 24 
months:  7.6% 
 
 
Reduction 
from 85 
minutes to 14 
minutes to re-
fill prescrip-
tion; Transpor-
tation costs 
cut to 1/3. 
HR costs 
lower, not 
quantified 
Trained PLWH, 
supply chain 
that can sup-
port 3-month 
med delivery 
Tete Province, 
Mozambique18,25 
2/2008 – 
12/2012 
PLWH form 
groups of six 
who share re-
sponsibility of 
picking up med-
ications and dis-
8,181 receiv-
ing medication 
through CAGs 
in study, 
which is  50% 
of active ART 
cohort within 
demonstration 
program;  
Overall, 
Frequency, 
Location 
On 1st line ART 
for ≥6 months; 
CD4≥200; no 
OI or side ef-
fects  
Monthly, in 
the com-
munity for 
5 of6 mem-
bers, while 
one mem-
ber attends 
clinic to 
pick up 
meds for 
Clinic visit 
every six 
months , 
which in-
cludes clinical 
consultation 
and blood test 
(CD4); group 
card record 
keeping 
Retention at 
12, 24, 36, 48 
months: 
97.7%, 96%, 
93.4%, 91.8%; 
Mortality per 
100 person 
years: 2.1  
LTFU per 100 
person years: 
Reduced costs 
and time bur-
den on pa-
tients; 28% of 
members 
shared trans-
portation costs
49.6% reduc-
tion in clinic 
visits, 62% 
reduction of 
ART refill vis-
its 
Lay Health Ser-
vice Providers 
to ensure links 
between 
community 
groups and 
health facili-
ties.  
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Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
tributing them 
to group month-
ly. SOC is 
monthly clinic 
visits by all. 
  
17,272 receiv-
ing care this 
way country-
wide, includ-
ing 276 chil-
dren. 
Rural 
the group. 1.0 
 
Kosirai, Western 
Kenya 24 
March 2006 – 
March 2007 
CHWs deliver 
medications, 
screen, and pro-
vide adherence 
support monthly 
at home.  SOC is 
monthly clinic 
visits served by 
full medical 
staff. 
100, 5% of ac-
tive ART co-
hort in clinic 
that was stud-
ied. 
Rural 
Health Ser-
vice Provid-
er, Location 
≥18 years old; 
clinically stable 
on ART for ≥3 
months; no 
adherence is-
sues; house-
hold members 
aware of pa-
tients’ HIV sta-
tus; no WHO 
stage 3 or 4 
condition; no 
pregnancy; no 
hospitalizations
Monthly, in 
the home 
by commu-
nity health 
workers 
with sec-
ondary ed-
ucation, 
training and 
PDA with 
decision 
support 
tools 
CCC assessed 
patient symp-
toms (using 
PDA) vital 
signs, adher-
ence to ART, 
and opportun-
istic infection 
prophylaxis.  
Clinical con-
sultation eve-
ry 3 months 
with nurse, 
physician, and 
pharmacist. 
Blood test 
every 6 
months. 
LTFU: 5.2% vs 
4.5% 
No significant 
difference of 
results as 
compared to 
SOC. Compari-
son popula-
tion was 
based on ran-
dom sample.   
6.4 clinic visits 
vs 12.6  
Half the clinic 
visits 
CCCs with sec-
ondary educa-
tion and mo-
bile, computer-
based decision 
support tools 
Karabole, Ugan-
da 22 
185 enrolled 
in trial arm 
Health Ser-
vice Provid-
Eligible for 
treatment and 
Monthly at 
home by 
Weekly moni-
toring by 
Mortality: 
17% vs 12% 
Clinic staff was 
trained on ART 
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Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
March 2006-
May 2009 
Weekly, home-
based monito-
ring and adhe-
rence counse-
ling and mon-
thly ARV-
delivery by un-
paid volunteers 
with 6-monthly 
appointments at 
the clinic vs 
monthly hospi-
tal visits in the 
standard of ca-
re. 
Rural er, Frequen-
cy, Location 
willing to ac-
cept daily 
treatment sup-
port from a 
family member 
and weekly vis-
its by a trained 
community 
volunteer 
trained 
community 
volunteers 
trained volun-
teers looking 
for adverse 
reactions, ad-
herence (pill 
counts), and 
clinical prob-
lems.  Six-
monthly visits 
to clinic for 
blood work 
and clinical 
review.  
Health center 
is staffed by 
two clinical 
officers, two 
nurses, and 
on mid-wife 
VL suppres-
sion (ITT): 
64.9% vs 
62.0% 
In multivariate 
analysis, the 
only factor 
significantly 
related to viral 
suppression 
was enroll-
ment in 
home-based 
cohort.  Odds 
ratio: 2.47 
(1.02-6.04) 
as part of the 
project; train-
ing for volun-
teers; boots, 
raincoats, bicy-
cles for volun-
teers.  Report 
forms for vol-
unteers 
Jinja, Uganda23 
February 2005 
through January 
2009 
Home-based, 
monthly follow-
up by trained 
field officers, 
859 enrolled 
in trial arm 
Rural and 
semi-urban 
Health Ser-
vice Provid-
er, Location 
Anyone eligible 
for treatment 
within 100 km 
from the clinic 
Monthly at 
home by 
trained field 
officers 
Monthly mon-
itoring at 
home, plus 
clinic visits at 
months 2, 6, 
and every six 
months 
thereafter. 
Virological
failure, LTFU, 
or withdrew: 
24% vs 27% 
Mortality (24 
months): 14% 
vs 14%  
 
First Year: 29 
vs 60 
Second Year: 
18 vs 54 
This includes 
transportation, 
lunch, child-
care costs, and 
$793 vs $838
This includes 
staff, 
transport, 
drugs, labs, 
sensitization, 
training, utili-
ties, supervi-
4-weeks of 
training for 
field officers 
over and above 
a college de-
gree; motorcy-
cles for field 
staff 
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Location, Dates, 
Summary 
(Source) 
Scope/Scale; 
Rural/Urban 
Optimization 
component 
Stratification 
metric 
ARV Distri-
bution Fre-
quency, Lo-
cation, and 
Provider 
Monitoring 
and Clinical 
Care 
Clinical Met-
ric: Interven-
tion vs SOC for 
similar popu-
lation  
* denotes sig-
nificant at 
p<.05  
Costs System Costs Necessary Supports 
with six-monthly 
clinic visits (after 
visits during 
months 2 and 
6).  SOC is 3-
monthly visits 
with monthly 
ARV pick-up. 
lost work time. sion and 
overheads, 
and capital.   
Main cause 
of higher 
costs of facil-
ity-based 
model is in-
creased con-
tacts with 
staff.  Home-
based pa-
tients had 
75% fewer 
clinic visits.   
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